Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Tanaka

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
British Journal of Cancer|October 14, 2016
IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinomaYuichiro Matsuoka, Hideki Nakayama, Ryoji Yoshida, et al.
Biochemistry and Biophysics Reports|September 30, 2021
miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinomaKenta Kawahara, Masashi Nagata, Ryoji Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2014
Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients revealed induction of immune responses and improved OSYoshihiro Yoshitake, Daiki Fukuma, Akira Yuno, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
British Journal of Cancer|October 14, 2016
IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinomaYuichiro Matsuoka, Hideki Nakayama, Ryoji Yoshida, et al.
Biochemistry and Biophysics Reports|September 30, 2021
miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinomaKenta Kawahara, Masashi Nagata, Ryoji Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2014
Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients revealed induction of immune responses and improved OSYoshihiro Yoshitake, Daiki Fukuma, Akira Yuno, et al.
Pageof 6